Biotech

All Articles

A nearer look at Fierce Biotech's Intense 15

.In this full week's incident of "The Top Line," our experts are actually diving right into Intense ...

Lilly faces period 2 failure of tau-targeting med

.The confetti is still soaring from Eli Lilly's party commemorating the approval of Alzheimer's cond...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of considerable management hirings, shooting...

Lykos will certainly inquire FDA to reevaluate its own selection adhering to rejection of MDMA therapy for trauma

.Following an inadequate showing for Lykos Rehabs' MDMA prospect for trauma at a recent FDA consulta...

AN 2 one-halfs census, stops phase 3 test after data let down

.AN2 Rehabs is reassessing its organization in action to poor midphase information, swearing to give...

Merck pays for $700M for bispecific, snooping autoimmune position and also possibility to challenge Amgen in cancer cells

.Merck &amp Co. is actually spending $700 thousand upfront to challenge Amgen in a blood cancer mark...

Gilead pays for J&ampJ $320M to leave licensing offer for seladelpar

.Along With Gilead Sciences on the verge of an FDA choice for its liver disease drug seladelpar, the...

' All hands on deck' at Lilly as peers target excessive weight market

.Chief executive officer David Ricks may observe the firms putting together camping tents at basecam...

Entero laying off personnel, leaving office as well as pausing R&ampD

.Bed Liquidators has actually switched Entero Rehabs white as a slab. The financial institution boug...

Exelixis drops ADC after choosing it is actually no match for Tivdak

.Exelixis is actually quiting on its tissue variable (TF)- targeting antibody-drug conjugate after w...